Carmelo Licciardello
Overview
Explore the profile of Carmelo Licciardello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzoni V, Chiavetta A, Curci V, Della Pepa G, Licciardello C, Panto F, et al.
Clinicoecon Outcomes Res
. 2021 Mar;
13:135-144.
PMID: 33664581
Objective: To perform an early economic evaluation of a system based on photodynamic advanced adjuvant therapy with photosensitizer RLP068/CI to facilitate the healing process of foot/leg skin lesions/ulcers with an...
2.
Meloni M, Acquati S, Licciardello C, Ludovico O, Sepe M, Vermigli C, et al.
Nutr Metab Cardiovasc Dis
. 2021 Feb;
31(3):776-781.
PMID: 33549455
Background And Aims: Diabetic foot (DF) disease is a current health and social burden. The authors aimed to identify the barriers to the DF management across Italy. Methods And Results:...
3.
Panto F, Adamo L, Giordano C, Licciardello C
Drugs Context
. 2020 Mar;
9.
PMID: 32158488
This article is the second part of a literature review concerning diabetic foot ulcers (DFUs) and the use of antimicrobial photodynamic therapy (PDT). PDT involves the topical application of a...
4.
Papa G, Degano C, Iurato M, Licciardello C, Maiorana R, Finocchiaro C
Cardiovasc Diabetol
. 2013 Jan;
12:20.
PMID: 23331854
Background: Macrovascular diseases (MVD) in type 2 diabetes mellitus (T2DM) are often considered all together, without discriminating the areas involved. The aim of our study was to analyse MVD prevalence...
5.
Papa G, Baratta R, Cali V, Degano C, Iurato M, Licciardello C, et al.
Acta Diabetol
. 2012 Jan;
49(5):387-93.
PMID: 22274553
In clinical practice, basal insulin dosage (BID) for the treatment for type 2 diabetes given as slow-acting analogues or NPH insulin varies widely when adjusted for body weight (UI/kg). In...